Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Heart (British Cardiac Society)·2026
Same author

The Impact of COVID-19 Infection and Vaccination on Myocarditis Incidence: A Comparative Analysis of Pre-, Peri-, and Post-Pandemic Eras.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Saphenous vein graft longevity: Novel approaches.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Impact of Cangrelor on Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome in High Bleeding Risk Patients.

The American journal of cardiology·2026
Same author

Comparison of clinical outcomes of acute myocardial infarction patients complicated with cardiogenic shock treated with intra-aortic balloon pump versus microaxial flow pump.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Editorial: Measuring what matters: Integrating coronary severity and ischemia to predict outcomes.

Cardiovascular revascularization medicine : including molecular interventions·2025

Related Experiment Video

Updated: Dec 22, 2025

Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

7.4K

Bioresorbable Scaffolds: Current Technology and Future Perspectives.

Brian Forrestal1, Brian C Case1, Charan Yerasi1

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

Rambam Maimonides Medical Journal
|May 7, 2020
PubMed
Summary

Fully bioresorbable scaffolds (BRS) offer a "leave nothing behind" approach, overcoming limitations of metallic stents. Refinements in BRS design and care have addressed early challenges like scaffold thrombosis.

More Related Videos

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.5K
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.0K

Related Experiment Videos

Last Updated: Dec 22, 2025

Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

7.4K
Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.5K
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.0K

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Interventional Cardiology

Background:

  • Metallic drug-eluting stents (DES) improve clinical outcomes but cause vessel wall caging.
  • Fully bioresorbable scaffolds (BRS) aim to eliminate long-term foreign material, enabling vessel recovery.
  • Early BRS adoption faced challenges, including higher rates of scaffold thrombosis compared to metallic stents.

Purpose of the Study:

  • To review current bioresorbable scaffold (BRS) technologies.
  • To outline advancements in BRS design, implantation techniques, and patient management.
  • To address the learning curve and safety concerns from initial BRS trials.

Main Methods:

  • Review of current literature and clinical data on bioresorbable scaffold technologies.
  • Analysis of refinements in scaffold design, including material, structure, and drug-elution.
  • Evaluation of procedural strategies and post-procedural care protocols informed by early trial outcomes.

Main Results:

  • Significant improvements in BRS design have been achieved to enhance mechanical properties and resorption profiles.
  • Optimized procedural techniques and lesion selection criteria have been developed to minimize procedural risks.
  • Enhanced post-procedural care strategies have been implemented to mitigate adverse events like scaffold thrombosis.

Conclusions:

  • Bioresorbable scaffolds (BRS) represent a promising advancement over metallic stents, offering a 'leave nothing behind' solution.
  • Continuous innovation in BRS technology, coupled with refined clinical practices, is crucial for improving patient outcomes.
  • The evolution of BRS technology addresses earlier concerns, paving the way for wider clinical acceptance.